Global Antibiotic Market Size, Share, Opportunities and Trends By Type (Penicillin, Cephalosporins, Macrolides, Others), And Geography - Forecasts From 2019 to 2024

The global antibiotic market is projected to grow at a CAGR of 2.89% to reach a market value of US$69.970 billion by 2024.  The global antibiotics market is poised to grow at a sustainable rate in the forecast period due to the prevalence of microbial infections, growing research and development investment, rising healthcare expenditure and growing pharmaceutical industry. North America and Europe are expected to hold a significant market share due to the early adoption of innovations, the highest healthcare spending of the United States and the presence of major industry players in these regions. However, rising concerns of antibiotic resistance may hinder the market growth during the forecast period.

 

DRIVERS

Prevalence of microbial infections

Growing pharmaceutical industry

Increasing health expenditure worldwide

 

RESTRAINTS

Stringent regulatory procedures regarding approval of drugs and medical devices

Growing concerns regarding antibiotic resistance

 

INDUSTRY UPDATES

On June 25, 2019, Abbvie Inc. the company announced that it has entered into a definitive agreement with Allergan regarding its acquisition. The company will acquire Allergan in a cash transaction of USD 63 billion (approximately).

Pfizer, Inc., in its 2017-18 annual report announced that the company continues to lead the antibiotic industry and comprises of having the widest product portfolio for anti-infectives. In addition, the company is making certain strategic investments for the development of new therapies in the future.

 

Major industry players profiled as part of the report are GlaxoSmithKline plc., Pfizer Inc., Novartis Pharmaceuticals Corporation, AbbVie Inc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., MELINTA THERAPEUTICS, INC., Cipla Inc., Sun Pharmaceutical Industries Ltd., and Dr. Reddy’s Laboratories Ltd.

 

Segmentation

The global antibiotic market has been analyzed through following segments:

 

By Type

Penicillin

Cephalosporins

Macrolides

Others

 

By Geography

North America

USA

Canada

Mexico

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Spain

Others

 

Middle East and Africa

Saudi Arabia

Israel

Others

 

Asia Pacific

China

Japan

South Korea

India

Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY 

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Forces Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. GLOBAL ANTIBIOTIC MARKET BY TYPE

5.1. Penicillins

5.2. Cephalosporins

5.3. Macrolides

5.4. Others

6. GLOBAL ANTIBIOTIC MARKET BY GEOGRAPHY

6.1. North America

6.1.1. USA

6.1.2. Canada

6.1.3. Mexico

6.2. South America

6.2.1. Brazil

6.2.2. Argentina

6.2.3. Others

6.3. Europe

6.3.1. Germany

6.3.2. France

6.3.3. United Kingdom

6.3.4. Spain

6.3.5. Others

6.4. Middle East and Africa

6.4.1. Saudi Arabia

6.4.2. Israel

6.4.3. Others

6.5. Asia Pacific

6.5.1. China

6.5.2. Japan

6.5.3. South Korea

6.5.4. India

6.5.5. Others

7. COMPETITIVE INTELLIGENCE

7.1.  Competitive Benchmarking and Analysis

7.2.  Recent Investments and Deals

7.3. Strategies of Key Players

8. COMPANY PROFILES

8.1. GlaxoSmithKline plc.

8.2. Pfizer Inc.

8.3. Novartis Pharmaceuticals Corporation

8.4. AbbVie Inc.

8.5. Gilead Sciences, Inc.

8.6. F. Hoffmann-La Roche Ltd.

8.7. MELINTA THERAPEUTICS, INC. - THE ANTIBIOTICS COMPANY

8.8. Cipla Inc.

8.9. Sun Pharmaceutical Industries Ltd.

8.10. Dr. Reddy’s Laboratories Ltd.

LIST OF FIGURES

LIST OF TABLES

GlaxoSmithKline plc.

Pfizer Inc.

Novartis Pharmaceuticals Corporation

AbbVie Inc.

Gilead Sciences, Inc.

F. Hoffmann-La Roche Ltd.

MELINTA THERAPEUTICS, INC.

Cipla Inc.

Sun Pharmaceutical Industries Ltd.

Dr. Reddy’s Laboratories Ltd.